Top Quality Weight Loss Drug Lorcaserin CAS 616202-92-7

Basic info.

Lorcaserin

CAS: 616202-92-7

MF: C11H14ClN

MW: 195.692

Assay: 99%

Quality Standards: USP

Appearance: White to almost white crystalline powder

Package: 1kg/Foil bag

Place of Origin: China

Certification: ISO9001, ISO14000, KOSHER

MOQ: 10g  Packaging Details1kg/bag,100g/bag, 10g/bag

Delivery Time: 1-3 days

Payment Terms: T/T, Western union, Money gram

Supply Ability: 1000KGS/week

Description: 

Lorcaserin is a selective 5-HT2C receptor agonist, and in vitro testing of the drug showed reasonable selectivity for 5-HT2C over other related targets. 5-HT2C receptors are located almost exclusively in the brain, and can be found in the choroid plexus, cortex, hippocampus, cerebellum, amygdala, thalamus, and hypothalamus. The activation of 5-HT2C receptors in the hypothalamus is supposed to activate proopiomelanocortin (POMC) production and consequently promote weight loss through satiety.  

Applications:

A novel selective 5-HT2C-receptor agonist for the treatment of obesity. 

Lorcaserin is a new type of drug treatment of obesity, which belongs to the selective 5- HT 2C receptor agonist hydrochloride orally effective, Lorcaserin (Lorcaserin hydrochloride, BelviqTM) by the success of research and development America Arena company, in June 27, 2012 by the American FDA approval, adjuvant therapy for obesity or combined with at least 1 weight related complications overweight adult in low calorie diet and exercise on the basis of. The clinical research indicated that, the drug can effectively reduce the weight of obese and overweight patients, improve the metabolism of obesity related, and well tolerated.